Correlation Between Lyra Therapeutics and Fennec Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Lyra Therapeutics and Fennec Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyra Therapeutics and Fennec Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lyra Therapeutics and Fennec Pharmaceuticals, you can compare the effects of market volatilities on Lyra Therapeutics and Fennec Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyra Therapeutics with a short position of Fennec Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyra Therapeutics and Fennec Pharmaceuticals.

Diversification Opportunities for Lyra Therapeutics and Fennec Pharmaceuticals

-0.14

Correlation Coefficient

Lyra Therapeutics  Fennec Pharmaceuticals

Good diversification

The 3 months correlation between Lyra and Fennec is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Lyra Therapeutics and Fennec Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fennec Pharmaceuticals and Lyra Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyra Therapeutics are associated (or correlated) with Fennec Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fennec Pharmaceuticals has no effect on the direction of Lyra Therapeutics i.e., Lyra Therapeutics and Fennec Pharmaceuticals go up and down completely randomly.

Pair Corralation between Lyra Therapeutics and Fennec Pharmaceuticals

Given the investment horizon of 90 days Lyra Therapeutics is expected to under-perform the Fennec Pharmaceuticals. In addition to that, Lyra Therapeutics is 1.43 times more volatile than Fennec Pharmaceuticals. It trades about -0.02 of its total potential returns per unit of risk. Fennec Pharmaceuticals is currently generating about 0.07 per unit of volatility. If you would invest  539.00  in Fennec Pharmaceuticals on September 12, 2024 and sell it today you would earn a total of  75.00  from holding Fennec Pharmaceuticals or generate 13.91% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Lyra Therapeutics  vs.  Fennec Pharmaceuticals

Lyra Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Lyra Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Fennec Pharmaceuticals

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Fennec Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Fennec Pharmaceuticals exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Lyra Therapeutics and Fennec Pharmaceuticals

The main advantage of trading using opposite Lyra Therapeutics and Fennec Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyra Therapeutics position performs unexpectedly, Fennec Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fennec Pharmaceuticals will offset losses from the drop in Fennec Pharmaceuticals' long position.

The idea behind Lyra Therapeutics and Fennec Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.